---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-008671"
form_type: "8-K"
ticker: null
cik: "0001792581"
company_name: "Kiromic Biopharma, Inc."
filed_at: "2025-03-21T23:59:59+00:00"
generated_at: "2026-05-24T08:58:01.035692+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 1.0
calibrated_materiality_score: 1.0
confidence: "high"
source: SEC EDGAR
---

# Kiromic BioPharma files for Chapter 7 bankruptcy; board and officers depart

## Summary
- Filed voluntary Chapter 7 bankruptcy petition on March 21, 2025 in Delaware Bankruptcy Court.
- Chapter 7 trustee to be appointed to administer and possibly liquidate company assets.
- All four board members (Pietro Bersani, Michael Nagel, Mike Catlin, Pamela Misajon) resigned effective immediately.
- Terminated CFO Brian Hungerford, COO Leonardo Mirandola, and Chief of Staff Scott Dahlbeck on March 21, 2025.
- Board has zero members following resignations; control passes to trustee.

## SEC filing metadata
- accession: 0001437749-25-008671
- form_type: 8-K
- cik: 0001792581
- company_name: Kiromic Biopharma, Inc.
- filed_at: 2025-03-21T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 1.0
- calibrated_materiality_score: 1.0
- confidence: high
- sec_items: 1.03, 5.03
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1792581/000143774925008671/0001437749-25-008671-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1792581/000143774925008671/krbp20250321_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-008671
- JSON: https://secwatch.observer/filing/0001437749-25-008671.json
- Plain text: https://secwatch.observer/filing/0001437749-25-008671.txt

## Key facts
- Distress & Bankruptcy
  Kiromic Biopharma, Inc. entered chapter 7 in United States Bankruptcy Court for the District of Delaware (petition 2025-03-21).
  - Proceeding: chapter 7
  - Court: United States Bankruptcy Court for the District of Delaware
  - Petition: 2025-03-21
  source text: On March 21, 2025, Kiromic BioPharma, Inc. (the "Company") filed a voluntary petition for relief (the "Bankruptcy Filing") under the provisions of Chapter 7 of Title 11 of the United States Code, 11 U.S.C. §101 et seq. (the "Bankruptcy Code").
  evidence_url: https://www.sec.gov/Archives/edgar/data/1792581/000143774925008671/0001437749-25-008671-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.